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Abstract
A significant increase in the activity of neutrophil elastase (NE) and anti-NE-protection in the plasma were detected in 
children having bronchopulmonary dysplasia (BPD) complicated by pulmonary arterial hypertension (PAH) and chronic cor 
pulmonale (CCP). The changes revealed were more pronounced in patients with CCP. The plasma concentration of the NE was 
slightly reduced, which was probably associated with the activation of anti-NE and an increase in the α1-antitrypsin level. A 
gradual increase was noted in the plasma level of the matrix metalloproteinase-7 (MMP-7) in patients with an increase in the 
severity of the condition. In patients with cystic fibrosis (with and without CCP), the pronounced increase in the MMP-7 level was 
observed. In patients with cystic fibrosis (CF), even without the additional complication with PAH and CCP, the MMP-7 level was 
significantly higher than in those with congenital broncho-pulmonary malformations (CBPM).  The difference was increased in 
those patients with PAH and reached a maximum in those with CCP.
Keywords: neutrophil elastase; matrix metalloproteinase-7; bronchopulmonary dysplasia; pulmonary arterial hypertension; 
chronic cor pulmonale.
Introduction
According  to  modern  concepts,  pulmonary  arterial 
hypertension  (PAH)  is  a  multifactorial  pathology.  The 
pathogenesis of PAH involves various biochemical processes 
and  activities  of  different  cells.  The  increased  pulmonary 
vascular resistance is associated with several mechanisms 
including vasoconstriction, inflammation and thrombosis. In 
PAH,  a  reduction  in  the  endothelium-derived  vasodilators 
(nitric oxide, prostacyclin) and an increase in the thromboxane 
and  endothelin-1  levels  are  evident.  In  the  adventitia, 
an  increase  in  the  formation  of  the  extracellular  matrix 
components,  including  collagen,  elastin,  and  fibronectin  is 
also noted [1]. 
Usually,  the  right  ventricle  (RV)  operates  under 
relatively low pressure and does not tolerate the PAH-induced 
overload. With the increase in the RV myocardial mass, the 
need for oxygenation is increased. Over time, in the enlarged 
and altered RV myocardium, dystrophic and necrotic changes 
keep occurring.
It is well known that the increased redox process and 
the development of oxidative stress (OS) are the pathogenetic 
mechanisms  in  the  cardiovascular  and  bronchopulmonary 
pathologies, in the inflammations of any genesis. Structural 
membrane  disruption  by  the  OS  activates  the  proteolytic 
enzymes, endonucleases, and NO synthase. Any impairment 
against the OS background may be caused by a change in 
the enzyme activity (or their direct inactivation or oxidative 
damage of the nucleic acids encoding them and the activities 
of the transcription factors) [2].
Processes  occurring  in  the  body  during  tissue 
metabolism  have  been  developing  with  the  involvement 
of  various  enzymatic  systems  and,  chiefly,  the  proteolytic 
enzymes. It is believed that the action of the latter leads to a 
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reduction in the exudate viscosity and facilitates the removal 
of the heterogeneous respiratory products. Proteases influence 
the  metabolism  of  the  protein  degradation  products  with 
the formation of assimilable amino acids. In a healthy lung, 
the proteases play an important role in the maintenance of 
homeostasis  and  regulate  the  regeneration  and  reparation 
processes. Chronic inflammatory lung diseases are associated 
with  increased  protease  levels.  Functionally,  this  can  act 
positively against infection and inflammation, although only 
up to the point when the balance between the protective effects 
and destructive effects of the pulmonary proteases remains 
unbroken.  The  latter  effects  are  associated  not  only  with 
the protease activity, but also with the opposite controlling 
mechanism, namely with antiproteases. The main classes of 
the proteases present in the lung are serine, cysteine, aspartic, 
and metalloproteases. They can function within the cell as 
well as extracellularly. Neutrophil elastase (NE), the serine 
protease,  plays  the  main  role  in  this  regulation.  The  NE 
can directly control the inducible expression and biological 
properties of the other pulmonary proteases. The action of 
these proteases is multifaceted, as follows: in inflammation, 
they involve the recruited cells and increase their migration; 
the NEs initiate an immune response and are involved in 
killing the bacteria, apoptosis, phagocytosis, as well as mucin 
production. However, how these non-destructive processes of 
the main pulmonary proteases are disconnected in pulmonary 
diseases continues to remain unclear [3,4]. 
There is evidence that the state of the myocardial stroma 
is regulated by the matrix metalloproteinases (MMRs) and 
their tissue inhibitors (TIMPs). In patients with chronic heart 
failure, the protease levels correlate with the degree of the left 
ventricular hypertrophy and fibrosis [5]. The MMP-7, also 
known as matrilysin, is a “minimal domain MMP”. MMP-7 
is synthesized and secreted in the intact exocrine and mucosal 
epithelium of most, if not all, adult tissues. The formation of 
MMP-7 in the normal epithelium suggests that this enzyme is 
involved in normal homeostatic functions. A series of studies 
emphasizes the role of matrilysin in the innate immunity of the 
epithelium. All the tissues, which express MMP-7, are open to 
bacterial infections and are easily damaged. Therefore, MMP-
7 is the key regulator in the tissues exposed to the bacterial 
load, such as in patients with CF [6].
The aim was to study the complex changes in the phase 
of the protease - antiprotease balance in patients with BPD 
complicated by PAH and CCP.
Material and Methods
Between 2007 and 2011, we examined more than 240 
children with various forms of BPD. In general, these patients 
had CBPM and CF; in addition, the study included children 
with idiopathic fibrosing alveolitis. Patients were divided into 
3 groups: the 1st group included children with BPD without 
CCP and PAH (n=110); the 2nd group included children with 
BPD and PAH (n=80); the 3rd group included children with 
BPD complicated by PAH and CCP (n=52). As a control (the 
4th  group),  data  obtained  from  apparently  healthy  children 
without BPD were used (n=30). All the children were surveyed 
in the Scientific Center for Children’s Health of RAMS. All 
children were about the same age, although patients with CCP 
were slightly older than those patients without PAH and CCP.
Blood  was  collected  into  tubes  containing  heparin-
lithium. After 40 minutes of sedimentation, in the neutrophil-
enriched plasma, the NE concentration and the anti-NE and 
anti-cathepsin  G  (anti-CG)  activity  were  determined  with 
ELISA  using  standard  kits  of  “Bender  Medsystems”  and 
“Orgentic”.  The  MMP-7  concentration  was  determined 
by  ELISA  using  a  standard  kit  of  “Rand”.  The  NE 
activity  was  determined  spectrophotometrically  (DU  530 
spectrophotometer, Beckmann Coulter, USA) by measuring 
the  breakdown  intensity  of  N-metoxysuccinyl-ALA-ALA-
PRO-VAL-L-Nitroanilide at λ 440 nm. The plasma levels of 
α1-antitrypsin (α1-AT) and α2-macroglobulin (α2-MG) were 
determined  spectrophotometrically  using  the  Sentinel  kits 
(Italy); this method was adapted for the automatic analyzer 
“Synchron CX-5Δ” (Beckmann Coulter, USA).
Statistical analysis was performed using the statistical 
software “Statistica”. The differences between groups were 
verified  statistically,  significant  at  probability  forecasting 
(p<0.05). The  correlation  coefficient  was  computed  by  the 
Pearson method.
Results
As  shown  in Table  1,  the  NE  level  in  BPD  patients 
without PAH and CCP was not different from that in the control 
group. The PAH resulted in a significant increase in the NE 
level, while in the condition complicated by CCP a decrease in 
the NE level in the neutrophil-enriched plasma was observed. 
The NE levels in the patients of Groups 2 and 3 correlated 
with the α1-AT level (r=+0.49 and r=+0.6, respectively); at 
the same time, a negative correlation was revealed between 
the α1-AT concentrations and the anti-NE (r=-0.67 for  Group 
2 and r=-0.49 for Group 3) and anti-CG activities (r=-0.69 
for Group 2). The NE activity in the BPD patients (Groups 1 
and 2) was slightly increased compared with the control and 
significantly increased with CCP development. In Group 2 
patients, correlations between the NE activity and degree of 
PAH were detected (r=+0.57). The increase in the NE activity 
was accompanied by an almost two-fold increase in the anti-
CG activity. The anti-NE activity in the patients of Groups 1 
and 2 was slightly lower and higher in the Group 3 patients 
when compared with the control. In the patients with CCP, the 
anti-NE activity was much higher than in the Group 1 patients. 
Significant differences were evident in the anti-NE activity 
between Group 2 and Group 3 patients. Similar changes were 
observed in the α1-AT level. In patients with CCP, a significant 
increase was noted in the α1-AT level compared with Groups 
1 and 4. Noticeable fluctuations in the α2-MG level among 
the groups were not identified while a correlation between the 
α2-MG level and ages of the patients in Groups 1 and 2 was 
revealed (r=-0.64 and r=-0.61, respectively).
In light of these data, it was interesting to calculate the 
ratio of the amount of anti-NE and anti-CG antibody activities 
to NE activity. As evident from the Table 1, the anti-NE+anti-
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than the control; in patients with the PAH development, this 
ratio gradually increases, but not significantly different from 
the control. In CCP patients, despite the increase in anti-NE 
activity and especially in the anti-CG activity, this ratio is 
drastically reduced, which indicates a complete failure of the 
adaptation processes in Group 3 patients in response to a sharp 
activation of the proteolytic enzymes. It is known that CG does 
not activate the hydrolysis of the synthetic substrate Succinyl-
(L-ala)3-p-nitroanilide by elastase. We studied the activity of 
the NE on this substrate, to be able to get a complete picture 
of the NE activity. Thus, our results indicate that the CCP 
greatly increases both the NE activity and anti-NE activity; 
the plasma concentrations of NE slightly decreased, possibly 
as a result of the activation of the anti-NE protection and a 
change in the α1-AT level.
We  observed  a  gradual  increase  in  the  MMP-7 
concentration  in  the  BPD  patients  with  the  deteriorating 
condition and the development of PAH and CCP. Correlations 
were  also  detected  between  the  MMP-7  concentrations 
and  NE  level  (r=+0.51)  and  anti-CG  activity  (r=-0.44).  In 
patients with CF, a pronounced increase in the MMP-7 level 
was observed. As revealed in the Table, in patients with CF, 
even without the additional complications of PAH and CCP, 
the MMP-7 level was significantly higher than in those with 
CBPM. The difference was seen to increase in patients with 
PAH and reached a maximum in those with CCP.
Discussion
Over the recent years, proteolysis has been recognized 
as a special form of physiological regulation. The proteolytic 
enzymes regulate the degradation of the abnormal and mutated 
protein structures and the formation and modification of the 
hormones,  enzymes  and  physiologically  active  peptides. 
Proteolysis controls the concentration and quality of the 
main  bio-regulators,  the  functioning  of  which  determines 
the  entire  metabolism  [7]. The  azurophilic  granules  of  the 
polymorphonuclear  leukocytes  contain  two  neutral  serine 
proteases - NE and CG. The study of these enzymes is a rapidly 
evolving field of increasing interest due to their significance in 
the process of connective tissue degeneration.
It  is  known  that  some  antibiotics  specifically  inhibit 
different  steps  in  protein  synthesis.  The  quantity  of  the 
enzyme (given the immunological cross-reactivity) varies a 
little, although it includes both the active and fully non-active 
molecules. Under the influence of the regulatory effects, many 
enzymes are transformed from an active form to an inactive 
form according to the metabolic needs of the cells. In general, 
NE plays a dual role. On the one hand, the NE can perform not 
only the intracellular destruction of the gram-positive bacteria 
captured by the neutrophils, it can also destroy extracellularly, 
and may possibly play a role in bacterial killing, being a part of 
the neutrophil extracellular traps (NETs). The NET substances 
are  active  against  both  gram-positive  and  gram-negative 
bacteria; they can destroy the virulence factors that come into 
contact with the NETs. In addition to the direct destruction 
of  bacteria,  the  NE  plays  an  important  part  in  initiating 
inflammation and immunity, particularly, in the recruitment 
of the neutrophils and mucin gene expression [3]. The NE 
inactivates CD14 - a cellular receptor for lipopolysaccharides 
and reduces the inflammatory response to endotoxins. On the 
other hand, NE induces the expression of several cytokines, 
including the IL-8 production in the epithelial cells, destroys 
the phosphatidylserine receptors on the macrophage surfaces, 
thereby reducing their ability to remove the apoptotic cells 
[8]. The α1-AT exerts a similar influence, as well as an anti-
inflammatory  action. The  simultaneous  increase  in  the  NE 
activity and the α1-AT level can probably be attributed to 
the compensatory response of the organism in patients with 
advanced CCP [9, 10]. 
NE and CG are defined in increased amounts during 
chronic inflammation. We observed an increase in the anti-
CG  activity  among  all  the  patients  with  BPD,  particularly 
pronounced in Group 3 patients, which could be an indirect 
evidence  of  CG  activation  in  these  patients.  We  found  a 
correlation between the magnitude of pulmonary pressure (PP) 
Table 1.
Protease –antiprotease imbalance in BPD  patients
Parameters Group 1 Group 2 Group 3 Croup 4
NE, 
U/ml 53.4±2.0 50.6±4.6 80.5±6.2
р3/4<0.01 45.4±7.3
NE, 
ng/ml
119.3±5.7  
р1/4<0.001
189.2±18.4 
р2/4<0.01  
159.4±16.8 
р2/3<0.01 127.5±13.5
Anti-NE,
U/ml
307.5±11.7
р1/3<0.001
319.5±23.7
р2/3<0.01
431.0±20.7  
р3/4<0.01 331.4±18.0
Anti-CG,
U/ml
423.0±14.6  
р1/4<0.01 338.4±16.1 510.6±25.1  
р3/4<0.001 264.0±49.9
Anti-NE+
anti-CG, 
U/ml
16.4±1.3      
р1/3<0.05 18.4±3.4 12.4±1.3 
р3/4<0.05 19.4±2.4
α1-АТ, 
g/l
1.66±0.09    
р1/3<0.05 1.75±0.17 2.35±0.27 
р3/4<0.05 1.62±0.04 
α2-MG,
g/l 2.71±0.1 2.96±0.21 2.52±0.16 2.78±0.03
ММР-7,
ng/ml
3.15±0.07 
р1/2<0.01 
р1/3<0.001
3.66±0.14 
р2/4<0.01 
р2/3<0.01
6.77±0.8 
р3/4<0.001 3.05±0.15
MMP-7, 
ng/ml
(CBPM 
patients)
3.03±0.07 3.16±0.12 3.76±0.27
р3/4<0.05 3.05±0.15
MMP-7,
ng/ml
(CF patients) 
3.99±0.07 4.44±0.23 11.7±1.43 3.05±0.15
ММР-7
(CBPM+CF 
patients) 
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and the anti-NE (r=+0.4)   and anti-CG (r=+0.35)   activities in 
Group 1 patients. In Group 2 patients, the PP correlated with 
the NE activity (r=+0.57). There is evidence that CG plays 
an important role in the case of low NE elastolytic activity 
against  the  pulmonary  elastin;  it  is  capable  of  activating 
the dissolution of the elastin by elastase, in 5-6 times. The 
polymorphonuclear leukocytes contain an equimolar amount 
of  elastase  and  cathepsin  G  that  leads  to  marked  elastase 
activation [11].
 In 1947, Grabar suggested that natural autoantibodies 
(NAs) are a part of the physiological mechanism for cleansing 
an organism of its own catabolic products. These have been 
found to play a role in protection against the infectious agents 
and to exert homeostatic functions. 
The NAs are present in the circulation of normal human 
beings  and  other  mammalian  species  that  have  not  been 
exposed  prior  to  deliberate  immunization.  They  are  often 
directed against highly conserved epitopes and often bind to 
the ligands of varying chemical compositions with low affinity. 
The NAs are frequently directed to intracellular structures, 
rather than to cell-surface antigens. The NAs are detected in 
normal human serum, against the antigenic structure of almost 
all organs and tissues. The NAs to the blood cells are also seen. 
In early ’80s, it was found that the NAs to thyroxine interfered 
with the detection of the hormone by the radioimmunoassay 
method, giving inflated results. Perhaps, partly due to this, 
we identified an “inadequate” elevated NE level in Group 2 
patients with respect to the NE activity [12].
It is known that, in the formation of the antimicrobial 
barrier  and  the  excretion  of  the  antimicrobial  products, 
the epithelium provides the first line of defense against the 
invasive  pathogens.  Epithelial  cells  are  recruited  and  limit 
the inflammation in the field of lesion. Matrilysin should not 
be seen as an example of proteinase catalyzing the matrix, 
but rather as an extracellular enzyme being involved in the 
regulation of cell-cell and cell-matrix signal pathways [13]. 
Synthesized  in  significant  quantities  in  the  adult  tissues, 
MMP-7 is not detected during the fetal and early postnatal 
periods.  Probably,  the  bacterial  load  is  the  physiological 
signal required to trigger the MMP-7 expression in the intact 
epithelium. The MMP-7 over-expression is observed in those 
patients with emphysema, idiopathic syndrome, pneumonia, 
transplantation and is most pronounced in the lungs of the 
CF  patients.  The  bacteria  themselves  are  indirectly  the 
“substrate” for the MMP-7, and the presence of this substrate 
often regulates the production of all the MMPs. The matrilysin 
production is increased by 50 times in the epithelial tissue 
in contact with the bacteria although it is not potentiated by 
lipopolysaccharides [6].
It is interesting to note that the significant increase in 
the MMP-7 level in the CF patients was due to the addition 
of chronic viral and bacterial infections: the exacerbation of 
chronic sinusitis was seen in 4 patients, chronic hepatitis C in 2 
patients; Mycobacterium tuberculosis, Staphylococcus aureus, 
and Pseudomonas aeruginosa were detected in many of the CF 
patients. This is consistent with the data of Winkler MK et 
al. (2003), who found that the MMP-7, MMP-8, and MMP-9 
levels in the bronchoalveolar lavage fluid from sick children 
were significantly elevated compared with healthy individuals. 
It is known that in children with PAH, the timely treatment 
of respiratory tract infections is very important for protection 
from alveolar hypoxia, which occurs much more frequently 
in them than in adults. Any adverse effect on the lung tissue 
caused by the infections, toxic agents and pollutants increases 
the number of granulocytes and macrophages, which secrete 
the elastase. A significant increase in the proteolytic activity 
of the bronchoalveolar secretions leads to the destruction of 
the  pulmonary  tissue  and  primarily  the  elastic  fibers.  The 
inflammatory  process  itself  can  provide  the  persistence  of 
various  bacteria.  For  example,  the  human  defensins  may 
increase the adhesion of H. influenzae to the epithelial cells and 
thus predispose them to infestation. Currently, the interrelation 
between inflammation and fibrosis in the small airways has 
been revealed. Genetic differences may arise in response to 
the inflammation, proteolytic and protective mechanisms or 
susceptibility to latent viral infection.
The initially induced MMP-7 productions in the 
epithelium of the bronchi may subsequently be maintained 
with a low bacterial level. An interaction occurs between the 
NE and MMRs in the foci of the inflammation; in our study, 
the MMP-7 concentration correlated with the NE level in the 
CCP patients (r=+0,51). Proteases secreted by the epithelial 
cells may interact with each other, while maintaining the cycle 
of  inflammation.  A  large  number  of  MMRs  (1,3,7,8,9,12)   
can cleave and inactivate the α1-AT; however, the NE, CG 
and  proteinase-3  remain  active.  This  may  be  important  in 
the context of neutrophil activation and maintaining of the 
antimicrobial  activity.  In  CF,  even  in  the  presence  of  NE, 
there is a reduction in the removal of the apoptotic cells 
from the respiratory tract, especially, if the NE splintered the 
phosphatidylserine receptors on the macrophage surfaces [4]. 
Phagocytosis  of  the  apoptotic  cells  leads  to  their  effective 
removal after the destruction of the plasma membrane and the 
release of the potentially dangerous intracellular contents. It 
is shown that the BAL of the CF patients contains 3 U/ml of 
NE and 28 mU/ml of CG. The increase in the anti-CG activity 
may indicate an increase in the content and/or activity of CG 
[15].
Conclusion
A significant increase in the activity of NE and anti-
NE-protection in the plasma were detected in children having 
BPD complicated by PAH and CCP. The changes revealed 
were  more  pronounced  in  patients  with  CCP.  The  plasma 
concentration  of  the  NE  was  slightly  reduced,  which  was 
probably  associated  with  the  activation  of  anti-NE  and  an 
increase in the α1-antitrypsin level. A gradual increase was 
noted in the plasma level of the MMP-7 in patients with an 
increase in the severity of the condition. In patients with cystic 
fibrosis (with and without CCP), the pronounced increase in 
the MMP-7 level was observed. In patients with CF, even 
without the additional complication with PAH and CCP, the 
MMP-7  level  was  significantly  higher  than  in  those  with 
CBPM.  The difference was increased in those patients with 
PAH and reached a maximum in those with CCP.273 E. M. Vasilyeva et al / International Journal of BioMedicine 3(4) (2013) 269-273
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